Trial Profile
A Clinical Trial of Renin Profiling in Selection of Initial Antihypertensive Drug.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Feb 2024
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Amlodipine; Hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- 18 Apr 2012 Actual patient number is 185 according to ClinicalTrials.gov.
- 18 Apr 2012 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 18 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.